Get the Daily Brief
Latest Biotech News
Twist Bioscience Revises Fiscal Guidance Following Strong Q3 Growth
Twist Bioscience reported record Q3 2025 revenues of $96.1 million, marking an 18% year-over-year increase driven by 27% growth in next-generation sequencing and 7% growth in synthetic biology...
Breakthrough Genome Editing Technologies: Megabase-Scale Precision Achieved
Researchers from the Chinese Academy of Sciences led by Prof. Gao Caixia have developed two innovative genome editing platforms, collectively termed Programmable Chromosome Engineering (PCE)...
FDA Leadership Changes and Impact on Gene Therapy Approvals
The recent departure of Vinay Prasad as director of the FDA's Center for Biologics Evaluation and Research (CBER) marks a significant turning point in regulatory oversight of gene therapies....
Biotech Market Uncertainty Strains San Diego Life Sciences Hub
San Diego's once vibrant biotech ecosystem is facing a prolonged downturn marked by scarce funding, rising lab vacancy rates, and widespread layoffs. Industry professionals, including former...
Advanced AI and Deep Learning Models Enhance Cancer Diagnostics
Cutting-edge artificial intelligence applications are transforming oncological diagnostics by improving the precision and prediction of tumor characteristics. Notably, researchers have developed a...
Novel Therapeutics and Drug Developments in Oncology and Neurology
Recent breakthroughs include a two-in-one molecule targeting KRAS and MYC oncogenes developed at University of North Carolina, promising new avenues for difficult-to-treat cancers. Another advance...
Microplastics and Nanoplastics: Environmental and Human Health Impacts
Environmental scientists continue to unravel the pervasive distribution and biological effects of micro- and nanoplastics. Studies highlight novel methods for detecting plastic particles in human...
Breakthroughs in Machine Learning and AI Applications in Biotech
Machine learning models have been leveraged to accelerate biotech research and diagnostics. Applications include early prediction of stem cell-derived organoid quality, restaurant demand...
Advanced Imaging and Optical Technologies for Biomedical Research
Innovations in microscopy and imaging technologies are pushing the boundaries of biological research and diagnostics. Developments include a chip-based, label-free super-resolution microscopy...
Biopharma Financial Updates and Strategic Movements
Twist Bioscience reported an 18% rise in Q3 2025 revenues, driven by growth in synthetic biology and next-generation sequencing sectors, prompting a modest revision of its fiscal 2025 revenue...
Emerging Vaccine and Immunotherapy Developments
Recent advances in vaccine and immunotherapy research include Sophia Genetics' 16% revenue growth amid an expanded AstraZeneca breast cancer collaboration focused on AI-driven data integration to...
Precision Genome Editing Scales Megabase Alterations
Chinese researchers led by Professor Gao Caixia have achieved a breakthrough in genome editing by developing Programmable Chromosome Engineering (PCE) systems that enable megabase-scale precise...
FDA Cancer Regulator’s Intervention Affects Approval Outcomes
Reports reveal that Richard Pazdur, head of the FDA’s Oncology Center of Excellence, directly influenced the rejection of Replimmune’s melanoma drug RP1 by overruling the Center for Biologics...
Early Insights Into ALS Mutation and Therapeutic Targeting
Scientists at Case Western Reserve University report that the familial ALS-linked VAPB P56S mutation activates the integrated stress response (ISR) via mitochondrial dysfunction in motor neurons....
New Bacterial Therapy Bypasses Immune System in Cancer
Researchers at JAIST partnered with Daiichi Sankyo and the University of Tsukuba have unveiled an innovative cancer treatment using bacteria that operates independent of the immune system. This...
GSK and Hengrui Lead Biopharma Deals in Asia
GlaxoSmithKline struck deals with Jiangsu Hengrui Pharma to develop up to 12 medicines, including a PDE3/4 inhibitor HRS-9821 for COPD with a $500 million upfront fee and potential $12 billion...
Twist Bioscience Raises Fiscal Guidance on Strong Q3 Performance
Twist Bioscience reported an 18% revenue increase in fiscal Q3 2025, driven by 27% growth in next-generation sequencing and 7% in synthetic biology. The company shipped approximately 237,000...
Biopharma Industry Signals Through FDA Leadership Changes
FDA leadership upheavals, including the departure of Vinay Prasad from Center for Biologics Evaluation and Research (CBER), have stirred notable market reactions. Analysts anticipate benefits for...
Environmental Microplastics and Their Emerging Health Implications
Groundbreaking environmental and health studies reveal pervasive micro- and nanoplastics across terrestrial and aquatic ecosystems, human feces, and bloodstreams, raising alarming possibilities...
Cancer Immunotherapy and Tumor Microenvironment Advances
Recent breakthroughs highlight sophisticated immune-targeting strategies to combat tumors. Novel approaches include CAR macrophages engineered via mRNA extracellular vesicles to reduce lung...